Á¦74Â÷ ´ëÇѺñ´¢ÀÇÇÐȸ Á¤±âÇмú´ëȸ (DAY1) : 2022-10-05±³À°ÀÏÀÚ : 2022-10-05
±³À°Àå¼Ò : ¼¿ï COEX Room C ¿Ü 1°³·ë
±³À°ÁÖÁ¦ :
Á¦74Â÷ ´ëÇѺñ´¢ÀÇÇÐȸ Á¤±âÇмú´ëȸ (DAY1)ÁÖÃÖ±â°ü : ´ëÇѺñ´¢ÀÇÇÐȸ(19.2 ¸íĪº¯°æ ´ëÇѺñ´¢±â°úÇÐȸ)
´ã´çÀÚ : À̼¼Èñ
¿¬¶ôó : 02-573-8190
À̸ÞÀÏ :
urology@urology.or.kr ±³À°Á¾·ù : ºñ´¢ÀÇÇаú
Âü¼®¿¹»óÀοø : 900¸í
Èñ¸ÁÆòÁ¡ : 6Á¡ (ÀÏ¹Ý 4Á¡ / Çʼö 2Á¡)
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 6 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 110,000¿ø
ºñ°í #»çÀüµî·Ï ±âÁØ Àü¹®ÀÇ: 110,000¿ø Àü°øÀÇ: 77,000¿ø Çлý, ÀÎÅÏ: 55,000¿ø °£È£»ç, ¿¬±¸¿ø: 66,000¿ø Á¦¾àȸ»ç ¹× ÀÇ·á±â±âȸ»ç: 132,000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 10-05 Room C (203) 10:00~10:30 Report of Accredited Urologic-endoscopy Unit ÇѺ´±Ô(ÆÛÆåÆ®ºñ´¢ÀÇÇаúÀÇ¿ø)
±³À°½Ã°£ 10-05 Room C (203) 10:30~11:00 Understanding and application of prophylactic antibiotics in urology ÃÖ¼¼¹Î(°æ»óÀÇ´ë)
±³À°½Ã°£ 10-05 Room C (203) 11:00~11:30 Current Benign Urology ½Åµ¿±æ(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 10-05 Room C (203) 11:30~12:00 Nursing Law from an Urological Perspective ¼ÛÇÊÇö(¿µ³²ÀÇ´ë)
½Ä»ç 10-05 12:00~13:00 Á¡½É½Ä»ç ()
±³À°½Ã°£ 10-05 Room D (209) 13:00~13:05 DEVELOPMENT OF A DRUG SCREENING MODEL FOR RENAL CELL CARCINOMA THROUGH BIO 3D PRINTER-BASED CANCER-ON-A-CHIP ÃÖÁß¿ø(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 10-05 Room D (209) 13:05~13:10 CABOZANTINIB-LOADED BIODEGRADABLE POLY(LACTIC-CO-GLYCOLIC ACID) NANOPARTICLES: A NOVEL ADJUVANT THERAPEUTIC STRATEGY TO INHIBIT POST-NEPHRECTOMY METASTATIC RELAPSE IN HIGH-RISK LOCALIZED AND LOCALLY ADVANCED RENAL CELL CARCINOMA ÀÌÇý¿ø(±¹¸³¾Ï¼¾ÅÍ)
±³À°½Ã°£ 10-05 Room D (209) 13:10~13:15 TUMOR ASSEMBLOID DERIVED FROM PATIENTS WITH RENAL CELL CARCINOMA FOR PREDICTING THE THERAPEUTIC RESPONSE TO IMMUNE CHECKPOINT INHIBITORS °¹Î¿ë(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 10-05 Room D (209) 13:15~13:20 THE ROLE OF CYTOREDUCTIVE NEPHRECTOMY WITH IMMUNE CHECKPOINT INHIBITOR THERAPIES IN METASTATIC RENAL CELL CARCINOMA ¹ÚÁö¼ö(±¹¸³¼Ò·Ïµµº´¿ø)
±³À°½Ã°£ 10-05 Room D (209) 13:20~13:25 EFFICACY OF RECOMBINANT BACILLUS CALMETTE-GUÉRIN CONTAINING DLTA IN IN-VIVO THREE-DIMENSIONAL BIO-PRINTED BLADDER CANCER-ON-A-CHIP AND EX-VIVO ORTHOTOPIC MOUSE MODEL ÃÖÁß¿ø(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 10-05 Room D (209) 13:25~13:30 STING AGONIST ENCAPSULATING UREASE-POWERED NANOMOTOR FOR IMMUNOTHERAPY OF BLADDER CANCER Á¤½Âȯ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 10-05 Room D (209) 13:30~13:35 THERAPEUTIC TARGET FOR HIF-2¥Á ANTAGONIST-RESISTANT CLEAR CELL RENAL CELL CARCINOMA. À±¿µÀº(ÇѾçÀÇ´ë)
±³À°½Ã°£ 10-05 Room D (209) 13:35~13:40 ADDITION OF ONCOLYTIC VIRUS IS AS EFFECTIVE AS ADDITION OF CYTOREDUCTIVE NEPHRECTOMY TO THE FIRST-LINE TREATMENT OF ANTI-PD-1/ANTI-CTLA-4 ANTIBODIES IN THE MURINE METASTATIC RENAL CELL CARCINOMA MODEL ¹ÚÁö¼ö(±¹¸³¼Ò·Ïµµº´¿ø)
±³À°½Ã°£ 10-05 Room D (209) 13:40~13:45 COMPARISON OF THREE-DIMENSIONAL PROSTATE CANCER CELL CULTURE USING HYDROGEL, GENE EXPRESSION AND RESISTANCE TO ANTICANCER DRUG ¼Û¿øÈÆ(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 10-05 Room D (209) 13:45~13:50 IMMUNE CHECKPOINT MOLECULES-TARGETING RECOMBINANT DENDRITIC CELLS FOR THERAPEUTIC EFFECT ON PROSTATE CANCER ÃÖ¼¼¿µ(Áß¾ÓÀÇ´ë)
±³À°½Ã°£ 10-05 Room D (209) 13:50~13:55 IRREVERSIBLE ELECTROPORATION WITH HIGH-FREQUENCY PULSED ELECTRIC FIELD IN A BEAGLE PROSTATE MODEL À̹üÁø(¿ï»êÀÇ´ë)
Åä·Ð 10-05 Room D (209) 13:55~14:00 Åä·Ð ()
±³À°½Ã°£ 10-05 Room D (209) 14:00~14:05 ANTIFIBROSIS TREATMENT IMPROVES DETRUSOR OVERACTIVITY AND CHRONIC BLADDER PAIN ASSOCIATED WITH NEURAL REMODELING OF CENTRAL NERVOUS SYSTEM IN A MOUSE MODEL OF INTERSTITIAL CYSTITIS ±ÇÁعü(´ë±¸ÆÄƼ¸¶º´¿ø)
±³À°½Ã°£ 10-05 Room D (209) 14:05~14:10 A NOVEL THERAPEUTIC APPROACH: A STUDY ON THE MECHANISM OF BOTULINUM NEUROTOXIN-A TIBIAL NERVE PERINEURAL INJECTION FOR ALLEVIATION OF OVERACTIVE BLADDER SYMPTOMS ³ªÇö¼®(Ãæ³²ÀÇ´ë)
±³À°½Ã°£ 10-05 Room D (209) 14:10~14:15 OVERACTIVE BLADDER MEDICATION, HOW LONG SHOULD IT BE SUSTAINED? MIRABEGRON INTERFERES THE CENTRAL SENSITIZATION INDUCED BY THE MICE MODEL OF OVERACTIVE BLADDER ±ÇÁعü(´ë±¸ÆÄƼ¸¶º´¿ø)
±³À°½Ã°£ 10-05 Room D (209) 14:15~14:20 THERAPEUTIC EFFECTS OF AXITINIB, AN ANTI-ANGIOGENIC TYROSINE KINASE INHIBITOR FOR TARGETING INTERSTITIAL CYSTITIS ½ÅÁ¤Çö(ÀÌÈÀÇ´ë)
±³À°½Ã°£ 10-05 Room D (209) 14:20~14:25 OVEREXPRESSION OF TRANSIENT RECEPTOR POTENTIAL VANILLOID-4 (TRPV4) IN UROTHELIUM OF RAT URINARY BLADDER FOLLOWING BLADDER OUTLET OBSTRUCTION ±¸Èñ¸ð(Àü³²ÀÇ´ë)
±³À°½Ã°£ 10-05 Room D (209) 14:25~14:30 ANTI-ONCOGENIC EFFECTS OF DUTASTERIDE, A DUAL 5-ALPHA REDUCTASE INHIBITOR, IN BLADDER CANCER ±è¾Æ¶÷(°Ç±¹ÀÇ´ë)
±³À°½Ã°£ 10-05 Room D (209) 14:30~14:35 INVESTIGATION ON THE EFFECTS OF THE COVID-19 IN URINARY AND STOOL MICROBIOME WITH THE ASSOCIATION OF PROGRESSION OF BENIGN PROSTATIC HYPERPLASIA ¹ÚÁö¼ö(±¹¸³¼Ò·Ïµµº´¿ø)
±³À°½Ã°£ 10-05 Room D (209) 14:35~14:40 A PRELIMINARY STUDY FOR IDENTIFYING CORRELATION POLYSTYRENE MICROPLASTICS WITH SPERM QUALITY IN THE MOUSE. Źü½Ä(°í·ÁÀÇ´ë)
±³À°½Ã°£ 10-05 Room D (209) 14:40~14:45 THE EFFICACY AND SAFETY OF A HUMAN PERIRENAL ADIPOSE TISSUE-DERIVED STROMAL VASCULAR FRACTION IN AN INTERSTITIAL CYSTITIS RAT MODEL ÇÏÁö¿ë(°è¸íÀÇ´ë)
±³À°½Ã°£ 10-05 Room D (209) 14:45~14:50 PREVENTION OF URETHRAL FIBROSIS INDUCED BY TRANSFORMING GROWTH FACTOR BETA 1 USING SELECTIVE WNT/¥Â-CATENIN SIGNALING INHIBITORS IN A RAT MODEL À̽·Ä(Â÷ÀÇ´ë)
±³À°½Ã°£ 10-05 Room D (209) 14:50~14:55 METFORMIN AND SILDENAFIL PRESERVE AGAINST ISCHEMIA/REPERFUSION-INDUCED INJURY IN RAT URINARY BLADDERS ÀÌÀç±Ù(Ãæ³²ÀÇ´ë)
Åä·Ð 10-05 Room D (209) 14:55~15:00 Åä·Ð ()
±³À°½Ã°£ 10-05 Room D (209) 15:00~15:05 THE EFFICACY AND SAFETY OF RADIATION-FREE RETROGRADE INTRARENAL SURGERY: A PROSPECTIVE MULTICENTER-BASED RANDOMIZED CONTROLLED STUDY °Áر¸(°æºÏÀÇ´ë)
±³À°½Ã°£ 10-05 Room D (209) 15:05~15:10 STONE-FREE RATE OF ECIRS, PCNL, MINIPCNL AND SWL: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS ÀÌÁÖ¿ë(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 10-05 Room D (209) 15:10~15:15 A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS ON STONE-FREE RATE OF MINIMAL INVASIVE INTERVENTIONAL THERAPY FOR RENAL STONES INCLUDING UMP, MINIPCNL, MICROPCNL, RIRS AND SWL ÀÌÁÖ¿ë(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 10-05 Room D (209) 15:15~15:20 SILODOSIN VERSUS TAMSULOSIN FOR MEDICAL EXPULSIVE THERAPY OF URETERAL STONES: AN UPDATED SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS ÀÌÁÖ¿ë(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 10-05 Room D (209) 15:20~15:25 IS ULTRASONOGRAPHY FOR UROLITHIASIS ACCURATE ENOUGH FOR CLINICAL MANAGEMENT DECISION MAKING? Yen-Cheng Pan(Launceston General Hospital)
±³À°½Ã°£ 10-05 Room D (209) 15:25~15:30 COMPARISON OF UROLITHIASIS CT WITH CLARI CT APPLIED TO FILTERED BACK PROJECTION (FBP), STATISTICAL ITERATIVE RECONSTRUCTION (IR), KNOWLEDGE-BASED ITERATIVE MODEL RECONSTRUCTION (IMR) : A PHYSICAL HUMAN PHANTOM STUDY ½ÉÀçÇå(Áß¾ÓÀÇ´ë)
±³À°½Ã°£ 10-05 Room D (209) 15:30~15:35 DEVELOPMENT OF S.T.O.N.E.S. (STONE SIZE, TOPOGRAPHY, OBESITY, NUMBER OF STONES, EXPOSURE, SKIN TO STONE DISTANCE) NEPHROLITHOMETRY SCORING IN PREDICTING THE STONE FREE RATE OF EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY IN UNCOMPLICATED RENAL STONES Eduardo Añonuevo(Victoriano Luna Medical Center)
±³À°½Ã°£ 10-05 Room D (209) 15:35~15:40 COMPARISON OF MINI-PERCUTANEOUS NEPHROLITHOTOMY AND RETROGRADE INTRARENAL SURGERY WITH 1-2CM SIZED RENAL STONES ¹®Çü¿ì(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 10-05 Room D (209) 15:40~15:45 COMPARISON BETWEEN MULTISESSION RETROGRADE INTRARENAL SURGERY AND PERCUTANEOUS NEPHROLITHOTOMY FOR RENAL STONES > 3CM ½ÅÁ¤Çö(ÀÌÈÀÇ´ë)
±³À°½Ã°£ 10-05 Room D (209) 15:45~15:50 CAN URINARY STONES PHANTOM BE USED AS AN ARTIFICIAL SUBSTITUTE FOR RESEARCH? Matthew Chau(Royal Perth Hospital)
±³À°½Ã°£ 10-05 Room D (209) 15:50~15:55 BETTER TARGETING STRATEGIES DURING LITHOTRIPSY BY IN VITRO AND IN VIVO STUDY CONSIDERING RESPIRATION REGULARITY ±è½ÃÇö(¼¿ïÀÇ´ë)
Åä·Ð 10-05 Room D (209) 15:55~16:00 Åä·Ð ()
±³À°½Ã°£ 10-05 Room D (209) 16:00~16:05 GERMLINE DNA-REPAIR GENES AND HOXB13 MUTATIONS IN KOREAN MEN WITH METASTATIC PROSTATE CANCER : DATA FROM A LARGE KOREAN COHORT ¼Û»óÇå(¼¿ïÀÇ´ë)
±³À°½Ã°£ 10-05 Room D (209) 16:05~16:10 METASTASIS-PRONE GENES REVEALED BY TARGETED SEQUENCING IN PROSTATE CANCER Á¤½Âȯ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 10-05 Room D (209) 16:10~16:15 PREVALENCE OF BRCA1 AND BRCA2 GENETIC ALTERATIONS IN KOREAN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER - A SINGLE CENTER DATA OF 51 SAMPLES ÇÑÇöÈ£(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 10-05 Room D (209) 16:15~16:20 THE CHANGE OF PROSTATE CANCER RISK-STRATIFICATION IN A SINGLE KOREAN PROVINCE BETWEEN 2003 – 2021: A MULTICENTER STUDY RECRUITING ENTIRE REGIONAL TRAINING HOSPITAL DATA °í¿µÈÖ(¿µ³²ÀÇ´ë)
±³À°½Ã°£ 10-05 Room D (209) 16:20~16:25 CHARACTERIZATION AND DIAGNOSTIC PERFORMANCE OF URINARY MICROBIOME IN PROSTATE CANCER ¾ÈÇö±Ô(ÀÌÈÀÇ´ë)
±³À°½Ã°£ 10-05 Room D (209) 16:25~16:30 CHROMOSOMAL INSTABILITY IN CELL-FREE DNA AS A PROGNOSTIC BIOMARKER OF METASTATIC HORMONE-SENSITIVE PROSTATE CANCER TREATED WITH ANDROGEN DEPRIVATION THERAPY ÀÌÃæ¾ð(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 10-05 Room D (209) 16:30~16:35 ETHNIC-SPECIFIC POLYGENIC RISK SCORE FOR TUMOR AGGRESSIVENESS AND EARLY-ONSET PROSTATE CANCER IN ASIANS ¼Û»óÇå(¼¿ïÀÇ´ë)
±³À°½Ã°£ 10-05 Room D (209) 16:35~16:40 EXPLANABLE MACHINE LEARNING MODELS FOR A DEEPER INSIGHT ON TREATMENT DECISION FOR LOCALIZED PROSTATE CANCER ÇÑÀåÈñ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 10-05 Room D (209) 16:40~16:45 PROGNOSTIC VALUE OF PROSTATE-SPECIFIC ANTIGEN KINETICS DURING TREATMENT OF ADVANCED PROSTATE CANCER WITH ABIRATERONE AND ENZALUTAMIDE: MULTICENTER ANALYSIS °º´Áø(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 10-05 Room D (209) 16:45~16:50 DISCOVERY OF PREDICTIVE MARKER FOR GOOD RESPONSE TO ENZALUTAMIDE IN METASTATIC CRPC: BASED ON MULTICENTER REAL-WORLD DATA ÇÑÀåÈñ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 10-05 Room D (209) 16:50~16:55 A NOMOGRAM FOR PREDICTION OF PROSTATE CANCER USING PROSTATE HEALTH INDEX IN KOREANS, PROSPECTIVE, MULTI-CENTER STUDY Á¤ÀçÈÆ(¼º±Õ°üÀÇ´ë)
Åä·Ð 10-05 Room D (209) 16:55~17:00 Åä·Ð ()